GGrantIndex
Sort

261,768 grants matching gene therapy

Pathobiology of Neurodegeneration in C9ORF72 repeat expansion

$2,328,355
Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2023 · NS

SCOR in Neurobiology of Sleep and Sleep Apnea

$2,328,073
University Of Pennsylvania · P50 · FY2004 · HL

Pathogenesis of CNS infection and injury

$2,327,831
Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS

Mechanisms Underlying Clearance of Persistent Infections

$2,327,831
Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

$2,327,780
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA

Longitudinal Epigenomic Tracking of the Reprogramming Process

$2,327,648
Michael P Snyder · Stanford University · P01 · FY2012 · GM

A defend and destroy approach to curing HIV

$2,327,582
David T Scadden · Harvard University · U19 · FY2015 · HL

Physiology, Psychology, and Genetics of Obesity

$2,327,508
Jack A. Yanovski · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD

Metabolic determinants of Mtb virulence, vulnerability and variation

$2,327,403
David Branch Moody · Brigham And Women'S Hospital · U19 · FY2025 · AI

Protection of Ischemic Myocardium

$2,327,380
Roberto Bolli · University Of Louisville · P01 · FY2009 · HL

Mechanisms that Govern Cardiomyocyte Proliferation and Remuscularization following Ventricular Injury

$2,327,307
Jianyi Zhang · University Of Alabama At Birmingham · P01 · FY2023 · HL

GENERAL CLINICAL RESEARCH CENTER

$2,327,236
University Of Texas Sw Med Ctr/Dallas · M01 · FY2000 · RR

Expression Genetics in Drug Therapy

$2,327,001
Wolfgang Sadee · Ohio State University · U01 · FY2010 · GM

Sleep, Aging and Circadian Rhythm Disorders

$2,326,831
Charles A Czeisler · Brigham And Women'S Hospital · P01 · FY2017 · AG

Systems Epigenomics of Persistent Bloodstream Infection

$2,326,682
Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U19 · FY2025 · AI

Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar Rhabdomyosarcoma

$2,326,552
Angela Nicole Koehler · Massachusetts Institute Of Technology · UM1 · FY2024 · CA

Center for the Development of Phenotype-Based Treatments of Autism Spectrum Disorder

$2,326,506
David G Amaral · University Of California At Davis · P50 · FY2017 · HD

Center of Cancer Nanotechnology Excellence at Johns Hopkins

$2,326,373
Peter C Searson · Johns Hopkins University · U54 · FY2014 · CA

BIOLOGY OF HEMATOPOIETIC STEM CELLS

$2,326,344
Fred Hutchinson Cancer Research Center · P50 · FY2004 · HL

TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and Tolerance

$2,326,227
Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE

Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease

$2,326,177
Huntington Potter · University Of Colorado Denver · R01 · FY2022 · AG

New approaches for understanding lipid movement in health and disease

$2,325,780
Stephen G Young · University Of California Los Angeles · P01 · FY2021 · HL

New approaches for understanding lipid movement in health and disease

$2,325,780
Stephen G Young · University Of California Los Angeles · P01 · FY2020 · HL

New approaches for understanding lipid movement in health and disease

$2,325,780
Stephen G Young · University Of California Los Angeles · P01 · FY2023 · HL

New approaches for understanding lipid movement in health and disease

$2,325,780
Stephen G Young · University Of California Los Angeles · P01 · FY2022 · HL